6 reports

  • HEPATITIS C THERAPEUTICS MARKET, RISK FACTORS FOR FIBROSIS PROGRESSION, 2016
  • 2.7.2 CHRONIC STAGE

Factors accelerating liver fibrosis progression include older age at the time of infection, excess alcohol consumption, cigarette smoking and iron overload.

  • Hepatitis
  • Bristol-Myers Squibb Company
  • Gilead Sciences, Inc.
  • Merck & Co., Inc.
  • Roche Group
  • HEPATITIS C THERAPEUTICS MARKET, RISK FACTORS FOR FIBROSIS
  • 4.6 Disease Progression

FACTORS ACCELERATING LIVER FIBROSIS PROGRESSION INCLUDE OLDER AGE AT THE TIME OF INFECTION, EXCESS ALCOHOL CONSUMPTION, CIGARETTE SMOKING AND IRON OVERLOAD.

  • Hepatitis
  • World
  • AbbVie Inc.
  • Gilead Sciences, Inc.
  • Merck & Co., Inc.

Overall, it is believed that cigarette smoking causes approximately ##% of all cancer deaths in the US.

  • Hepatitis
  • World
  • Market Size
  • Juno Therapeutics Inc.
  • Merck & Co., Inc.
  • RISK FACTORS AND COMORBIDITIES FOR HCC

Epidemiology BE DUE TO MEN BEING MORE LIKELY TO BE INFECTED WITH HBV AND HCV, TO CONSUME MORE ALCOHOL, TO SMOKE CIGARETTES, AND TO HAVE INCREASED IRON STORES (EL-SERAG AND RUDOLPH, 2007).

  • Hepatitis
  • Celsion Corporation
  • Eli Lilly & Co.
  • GlobalData's company
  • ThermoDox® group

THE IMPACT OF CHARACTERISTICS OF CIGARETTE SMOKING ON URINARY TRACT CANCER RISK: A META-ANALYSIS OF EPIDEMIOLOGIC STUDIES.

  • Hepatitis
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Novartis AG
  • Roche Group

Japan Tobacco Inc (JT Group) is a tobacco company that primarily manufactures cigarettes.

  • Hepatitis
  • HIV AIDS
  • Pharmaceutical
  • United States
  • Gilead Sciences, Inc.